Gene · 6241
Papers4,414
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 4,414
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| DEAD/H-box RNA helicase 10 promotes pancreatic cancer cell proliferation via ribonucleotide reductase M2. | World J Gastrointest Oncol | 2025 | 40977667 | PubTator, text mining | PubMed |
| Promising Cancer Vaccine for Glioblastoma Therapy: A Focus on mRNA Vaccine. | Cancer Med | 2025 | 40948290 | PubTator, text mining | PubMed |
| 1H, 13C and 15N backbone resonance assignment of the RNA binding motif 39 (RBM39) tandem RNA recognition motifs (RRM1-2). | Biomol NMR Assign | 2025 | 40944856 | PubTator, text mining | PubMed |
| Integrative analysis reveals ferroptosis-related genes with RRM2 as a key driver in endometriosis. | Gene | 2025 | 40939963 | PubTator, text mining | PubMed |
| Didox, a ribonucleotide reductase inhibitor with iron chelator properties, counteracts the in vitro and in vivo growth of rhabdomyosarcoma cells. | Biochem Pharmacol | 2025 | 40925467 | PubTator, text mining | PubMed |
| CUB domain-containing protein 1 signaling dysregulates gemcitabine metabolism contributing to therapeutic resistance in T24 cells. | PLoS One | 2025 | 40892739 | PubTator, text mining | PubMed |
| Long non-coding RNA-based single and combination independent prognostic biomarkers for hepatocellular carcinoma. | Discov Oncol | 2025 | 40892177 | PubTator, text mining | PubMed |
| WEE1 inhibitor exerts synergistic effect with KRAS G12C inhibitor via MYBL2-RRM2 axis in KRASG12C-mutant lung cancer. | Cell Death Dis | 2025 | 40885709 | PubTator, text mining | PubMed |
| Approaches for Identifying LncRNA-Associated Proteins for Therapeutic Targets and Cancer Biomarker Discovery. | Targets (Basel) | 2025 | 40861865 | PubTator, text mining | PubMed |
| Knowledge graph-aided Bayesian active learning for top-K genetic interaction discovery. | Sci Rep | 2025 | 40854903 | PubTator, text mining | PubMed |
| Landscape analysis of m5C modification regulators unveils DNMT1-mediated dysregulated pyrimidine metabolism in hepatocellular carcinoma. | Clin Epigenetics | 2025 | 40847321 | PubTator, text mining | PubMed |
| Disulfidptosis-associated gene signature predicts prognosis and radioresistance in NSCLC. | Transl Oncol | 2025 | 40840079 | PubTator, text mining | PubMed |
| Immune-Modulating Dual-Targeted Nanomaterials for Low-Temperature Photothermal-Photodynamic-Chemodynamic Therapy of Osteosarcoma Targeting Tumor and Endothelial Cells. | ACS Nano | 2025 | 40834268 | PubTator, text mining | PubMed |
| USP18 promotes ferroptosis in lipopolysaccharide-induced human kidney organoids by stabilizing STING1. | Cell Biol Toxicol | 2025 | 40833519 | PubTator, text mining | PubMed |
| Viral Reprogramming of Nucleotide Synthesis and Its Impact on Viral Infection. | J Med Virol | 2025 | 40832900 | PubTator, text mining | PubMed |
| Identification of biomarkers and potential therapeutic targets of breast cancer using bioinformatics analysis. | Medicine (Baltimore) | 2025 | 40826700 | PubTator, text mining | PubMed |
| Dynamic shifts in trophoblast nucleos(t)ide metabolism, transport, and adenosine signaling during gestation and preterm birth. | Sci Rep | 2025 | 40825832 | PubTator, text mining | PubMed |
| Retraction Notice to: MicroRNA-4500 Inhibits Migration, Invasion, and Angiogenesis of Breast Cancer Cells via RRM2-Dependent MAPK Signaling Pathway. | Mol Ther Nucleic Acids | 2025 | 40822031 | PubTator, text mining | PubMed |
| FEN1 plays a key role in the transition from HSIL to CSCC. | Sci Rep | 2025 | 40820150 | PubTator, text mining | PubMed |
| Multifaceted Human Antigen R (HuR): A Key Player in Liver Metabolism and MASLD. | Livers | 2025 | 40809813 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6241/papers?page=8